AAAAAA
Results:
1-23
|
Results: 23
Authors:
Bernasconi, E
Vernazza, PL
Bernasconi, A
Hirschel, B
Citation: E. Bernasconi et al., HIV transmission after suspension of highly active antiretroviral therapy, J ACQ IMM D, 27(2), 2001, pp. 209-209
Authors:
Rossi, M
Flepp, M
Telenti, A
Schiffer, V
Egloff, N
Bucher, H
Vernazza, P
Bernasconi, E
Weber, R
Rickenbach, M
Furrer, H
Citation: M. Rossi et al., Disseminated M-avium complex infection in the Swiss HIV cohort study: Declining incidence, improved prognosis and discontinuation of maintenance therapy, SWISS MED W, 131(31-32), 2001, pp. 471-477
Authors:
Bernasconi, E
Jost, J
Ledergerber, B
Hirschel, B
Francioli, P
Sudre, P
Citation: E. Bernasconi et al., Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000, SWISS MED W, 131(29-30), 2001, pp. 433-437
Authors:
Bernasconi, E
Uhr, M
Magenta, L
Ranno, A
Telenti, A
Citation: E. Bernasconi et al., Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy, AIDS, 15(8), 2001, pp. 1081-1082
Authors:
Furrer, H
Opravil, M
Rossi, M
Bernasconi, E
Telenti, A
Bucher, H
Schiffer, V
Boggian, K
Rickenbach, M
Flepp, M
Egger, M
Citation: H. Furrer et al., Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study, AIDS, 15(4), 2001, pp. 501-507
Authors:
Friedl, AC
Ledergerber, B
Flepp, M
Hirschel, B
Telenti, A
Furrer, H
Bucher, HC
Bernasconi, E
Weber, R
Citation: Ac. Friedl et al., Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy - The Swiss HIV Cohort Study, AIDS, 15(14), 2001, pp. 1793-1800
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Authors:
Fellay, J
Boubaker, K
Ledergerber, B
Bernasconi, E
Furrer, H
Battegay, M
Hirschel, B
Vernazza, P
Francioli, P
Greub, G
Flepp, M
Telenti, A
Citation: J. Fellay et al., Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study, LANCET, 358(9290), 2001, pp. 1322-1327
Authors:
Gobbi, C
Tosi, C
Stadler, C
Merenda, C
Bernasconi, E
Citation: C. Gobbi et al., Recurrent myelitis associated with herpes simplex virus type 2, EUR NEUROL, 46(4), 2001, pp. 215-218
Authors:
Katlama, C
Clotet, B
Plettenberg, A
Jost, J
Arasteh, K
Bernasconi, E
Jeantils, V
Cutrell, A
Stone, C
Ait-Khaled, M
Purdon, S
Citation: C. Katlama et al., The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial, AIDS, 14(7), 2000, pp. 781-789
Authors:
Aebi, C
Battegay, M
Bernasconi, E
Biedermann, K
Cheseaux, JJ
Drack, G
Erb, P
Flepp, M
Francioli, P
Furrer, HJ
Gianinazzi, MP
Gyr, T
Hirschel, B
Hosli, I
Hug, I
Irion, O
Keller, K
Kind, C
Laubereau, B
Lauper, U
Lorenzi, P
Matter, L
Nadal, D
Perrin, L
Rickenbach, M
Rudin, C
Schreyer, A
Schupbach, J
Telenti, A
Vernazza, P
Wolf, K
Wunder, D
Wyler, CA
Giaquinto, C
Ruga, E
De Rossi, A
Grosch-Worner, I
Seel, K
Schafer, A
Mok, J
Johnstone, F
Jimenez, J
Garcia-Rodriguez, MC
Bates, I
de Jose, I
Hawkins, F
de Gevara, CL
Pena, JM
Garcia, JG
Lopez, JRA
Asensi-Botet, F
Otero, MC
Perez-Tamarit, D
Ridaura, S
Gregori, P
de la Torre, R
Scherpbier, H
Kreyenbroek, M
Boer, K
Bohlin, AB
Lindgren, S
Ehrnst, A
Belfrage, E
Lidman, K
Christensson, B
Levy, J
Hainaut, M
Peltier, A
Barlow, P
Wibaut, S
Lecroart, MC
Ferrazin, A
Bassetti, D
De Maria, A
Gotta, C
Mur, A
Paya, A
Vinolas, M
Lopez-Vilchez, MA
Martinez-Gomez, P
Carreras, R
Coll, O
Fortuny, C
Boguna, J
Caro, MC
Canet, Y
Pardi, G
Ravizza, M
Guerra, B
Lanari, M
Bianchi, S
Bovicelli, L
Prati, E
Duse, M
Scaravelli, G
Stegagno, M
De Santis, M
Semprini, AE
Savasi, V
Vigano, A
Probizer, FR
Maccabruni, A
Bucceri, A
Rancilio, L
Taylor, GP
Lyall, H
Penn, Z
Valerius, NH
Martinelli, P
Buffolano, W
Sansone, M
Tibaldi, C
Ziarati, N
Benedetto, C
Niemiec, T
Horban, A
Citation: C. Aebi et al., Combination antiretroviral therapy and duration of pregnancy, AIDS, 14(18), 2000, pp. 2913-2920
Authors:
Rutschmann, OT
Vernazza, PL
Bucher, HC
Opravil, M
Ledergerber, B
Telenti, A
Malinverni, R
Bernasconi, E
Fagard, C
Leduc, D
Perrin, L
Hirschel, B
Citation: Ot. Rutschmann et al., Long-term hydroxyurea in combination with didanosine and stavudine for thetreatment of HIV-1 infection, AIDS, 14(14), 2000, pp. 2145-2151
Authors:
Bernasconi, E
Magenta, L
Piffaretti, JC
Carota, A
Moccetti, T
Citation: E. Bernasconi et al., Are nelfinavir-containing regimens effective as second-line triple therapy?, AIDS, 14(1), 2000, pp. 95-96
Authors:
Furrer, H
Opravil, M
Bernasconi, E
Telenti, A
Egger, M
Citation: H. Furrer et al., Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis, LANCET, 355(9222), 2000, pp. 2217-2218
Authors:
Bernasconi, E
Gayer, R
Busolini, E
Mombelli, G
Citation: E. Bernasconi et al., Autochthonic and imported severe leptospirosis in southern Switzerland, SCHW MED WO, 130(41), 2000, pp. 1487-1492
Authors:
Vernazza, PL
Bernasconi, E
Hirschel, B
Citation: Pl. Vernazza et al., HIV superinfection: myth or reality?, SCHW MED WO, 130(31-32), 2000, pp. 1101-1104
Authors:
Bassetti, S
Battegay, M
Furrer, H
Rickenbach, M
Flepp, M
Kaiser, L
Telenti, A
Vernazza, PL
Bernasconi, E
Sudre, P
Citation: S. Bassetti et al., Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?, J ACQ IMM D, 21(2), 1999, pp. 114-119
Authors:
Passeraub, PA
Besse, PA
Bayadroun, A
Hediger, S
Bernasconi, E
Popovic, RS
Citation: Pa. Passeraub et al., First integrated inductive proximity sensor with on-chip CMOS readout circuit and electrodeposited 1 mm flat coil, SENS ACTU-A, 76(1-3), 1999, pp. 273-278
Authors:
Sudre, P
Pfyffer, GE
Bodmer, T
Prod'hom, G
Furrer, H
Bassetti, S
Bernasconi, E
Matter, L
Telenti, A
Strassle, A
Jacques, JP
Weber, R
Citation: P. Sudre et al., Molecular epidemiology of tuberculosis among HIV-infected persons in Switzerland: A countrywide 9-year cohort study, INFECTION, 27(6), 1999, pp. 323-330
Authors:
Diez, B
Mellado, E
Rodriguez, M
Bernasconi, E
Barredo, JL
Citation: B. Diez et al., The NADP-dependent glutamate dehydrogenase gene from Penicillium chrysogenum and the construction of expression vectors for filamentous fungi, APPL MICR B, 52(2), 1999, pp. 196-207
Authors:
Ledergerber, B
Erard, V
Weber, R
Hirschel, B
Furrer, H
Battegay, M
Vernazza, P
Bernasconi, E
Opravil, M
Kaufmann, D
Sudre, P
Francioli, P
Telenti, A
Citation: B. Ledergerber et al., AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy - The Swiss HIV Cohort Study, J AM MED A, 282(23), 1999, pp. 2220-2226
Authors:
Furrer, H
Egger, M
Opravil, M
Bernasconi, E
Hirschel, B
Battegay, M
Telenti, A
Vernazza, PL
Rickenbach, M
Flepp, M
Malinverni, R
Citation: H. Furrer et al., Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy, N ENG J MED, 340(17), 1999, pp. 1301-1306
Authors:
Rutschmann, OT
Opravil, M
Iten, M
Malinverni, R
Vernazza, PL
Bucher, H
Bernasconi, E
Perrin, LH
Yerly, S
Hirschel, B
Citation: Ot. Rutschmann et al., Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up, ANTIVIR TH, 3, 1998, pp. 65-67
Authors:
Bernasconi, E
Battegay, M
Citation: E. Bernasconi et M. Battegay, Lamivudine for chronic hepatitis B, N ENG J MED, 339(24), 1998, pp. 1786-1786
Risultati:
1-23
|